Peritoneal Metastasis Center
Kishiwada Tokushukai Hospital, Osaka
Focused on peritoneal metastasis and peritoneal surface oncology,
particularly in gastric cancer.
Clinical assessment is led by Dr. Yutaka Yonemura, whose academic work includes
intraperitoneal chemotherapy, HIPEC, and cytoreductive surgery.
Yutaka Yonemura, M.D., Ph.D.
米村 豊
Director, Peritoneal Metastasis Center
Dr. Yutaka Yonemura has worked in peritoneal surface oncology, focusing on gastric cancer with peritoneal metastasis.
His work includes intraperitoneal chemotherapy, HIPEC, and cytoreductive surgery.
Selected Publications
Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Patients with Peritoneal Metastasis from Gastric Cancer
Effects of neoadjuvant intraperitoneal/systemic chemotherapy (NIPS) in patients with gastric cancer with peritoneal metastasis
Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by bidirectional chemotherapy prior to cytoreductive surgery and HIPEC
Long term survival after cytoreductive surgery combined with perioperative chemotherapy in gastric cancer patients with peritoneal metastases
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal metastases from gastric cancer: a multi-institutional cohort study (PSOGI)
History of peritoneal surface malignancy treatment in Japan
All cases require individual assessment based on diagnosis, prior treatment,
imaging findings, pathology, and current general condition.